@article{Dobson:12597,
      recid = {12597},
      author = {Dobson, William D.},
      title = {THE BST CASE},
      address = {1996},
      number = {1800-2016-142163},
      series = {Staff Paper 397},
      pages = {32},
      year = {1996},
      abstract = {Recombinant Bovine Somatotropin (rBST) is a milk  production enhancer, a product of industrial microbiology.  First approved for commercial sale in the United States  (U.S.) by the Food and Drug Administration (FDA) in 1994,  rBST has been immersed in controversy since the early  1980s. Conflicts among major players with interests in rBST  have shaped the product's image and influenced its use.  Players with interests in the product include government  agencies, Monsanto Corporation (the first firm approved to  sell rBST), other firms seeking commercial approval to sell  rBST, dairy farmers, and consumers.},
      url = {http://ageconsearch.umn.edu/record/12597},
      doi = {https://doi.org/10.22004/ag.econ.12597},
}